Skip to main content
. 2023 Oct 17;14(6):100806. doi: 10.1016/j.jaim.2023.100806

Table 2.

Distribution of patients according to Prakriti.

Treatment Group (n = 31) (%) Placebo Group (n = 31) (%)
Kaphapradhan 13 (41.96%) 19 (61.29%)
Pittapradhan 9 (29.03%) 8 (25.80%)
Vatapradhan 9 (29.03%) 4 (12.90%)